Citigroup Inc Inogen Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Inogen Inc stock. As of the latest transaction made, Citigroup Inc holds 17,385 shares of INGN stock, worth $163,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,385

Previous 5,430 220.17%

Holding current value

$163,071

Previous $44,000 281.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$7.67 - $12.98 $91,694 - $155,175	11,955 Added 220.17%	17,385 $168,000
Q2 2024 Aug 12, 2024	BUY	$6.3 - $8.95 $6,111 - $8,681	970 Added 21.75%	5,430 $44,000
Q1 2024 May 10, 2024	BUY	$5.26 - $10.15 $5,691 - $10,982	1,082 Added 32.03%	4,460 $35,000
Q4 2023 Feb 09, 2024	BUY	$4.21 - $6.32 $14,175 - $21,279	3,367 Added 30609.09%	3,378 $18,000
Q3 2023 Nov 09, 2023	SELL	$5.14 - $11.28 $35,640 - $78,215	-6,934 Reduced 99.84%	11 $0
Q2 2023 Aug 10, 2023	SELL	$10.01 - $13.86 $35,825 - $49,604	-3,579 Reduced 34.01%	6,945 $80,000
Q1 2023 May 11, 2023	SELL	$11.88 - $26.0 $37,635 - $82,368	-3,168 Reduced 23.14%	10,524 $131,000
Q4 2022 Feb 09, 2023	BUY	$19.14 - $24.55 $55,123 - $70,704	2,880 Added 26.64%	13,692 $269,000
Q3 2022 Nov 10, 2022	BUY	$22.74 - $31.8 $34,428 - $48,145	1,514 Added 16.28%	10,812 $263,000
Q2 2022 Aug 10, 2022	SELL	$22.88 - $35.28 $189,286 - $291,871	-8,273 Reduced 47.08%	9,298 $225,000
Q1 2022 May 12, 2022	SELL	$28.1 - $35.25 $107,482 - $134,831	-3,825 Reduced 17.88%	17,571 $570,000
Q4 2021 Feb 10, 2022	BUY	$29.66 - $44.0 $213,700 - $317,020	7,205 Added 50.77%	21,396 $727,000
Q3 2021 Nov 10, 2021	BUY	$43.09 - $82.26 $611,490 - $1.17 Million	14,191 New	14,191 $611,000

Others Institutions Holding INGN

# of Institutions

143

Shares Held

21M

Call Options Held

119K

Put Options Held

149K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account